FDA Approved New Insulin Dosage App for Diabetes
The MODI app by DreaMed Diabetes offers insulin dosage recommendations to adults with type 2 diabetes.
Updated on Sept. 28, 2026 in Diabetes
Live Poll
Do you trust smartphone apps to make personalized medical treatment decisions for your health?
The U.S. Food and Drug Administration has granted clearance to the DreaMed Diabetes MODI app. This technology provides personalized insulin dosage recommendations to adults living with type 2 diabetes.
Why it matters
Many patients with type 2 diabetes currently struggle to reach recommended glucose levels because insulin dosage adjustments are restricted by the time between clinic visits. This tool aims to address that gap by providing guidance between professional appointments.
The FDA clearance authorizes the MODI app to provide insulin dosage recommendations for adults with type 2 diabetes, a population that includes over 8 million insulin injection users in the U.S. The technology is designed to assist the 85% of insulin users who primarily rely on injections.
The players
FDA
The federal agency responsible for overseeing the safety and efficacy of medical devices and pharmaceuticals in the United States.
DreaMed Diabetes
A healthcare technology company based in Kfar Saba, Israel, that develops software for diabetes management.
The details
The app works by analyzing a user's glucose patterns and treatment data to generate specific dosing recommendations. By communicating these insights directly to patients between clinic visits, the system functions as a decision-support tool that does not require immediate physician approval for every suggested adjustment.
Timeline
DreaMed Diabetes was founded in 2014.
Mordechai Amir was killed on October 7.
Health Landscape
The FDA's Digital Health Software Precertification Program serves as the regulatory framework for evaluating novel diabetes management apps like MODI. This approval follows the established regulatory pattern for digital health tools aiming to increase patient autonomy in managing chronic conditions.
If you use insulin injections for type 2 diabetes, this technology may provide a new way to track and adjust your dosages between office visits. Discuss with your doctor whether an automated dosage tool is appropriate for your specific treatment plan and blood glucose management goals.
The takeaway
The MODI app represents an effort to bridge the gap in glucose management for adults relying on insulin injections. Consider speaking with your endocrinologist or primary care physician about how digital health apps might fit into your current diabetes care routine.
Further reading
Learn more about the latest innovations in Diabetes management.
Source note: This article includes information reported by Ynetnews.
Live Poll
Do you trust smartphone apps to make personalized medical treatment decisions for your health?
